Risperidone is thought to be able to inhibit or link dopamine at the D2 dopamine receptors. Manic symptoms may be reduced by limiting dopamine availability, according to research. The neuroadaptation of the synapse limits most psychiatric medicines. In reaction to an apparent dopamine deficit, the synapse can boost the receptor's dopamine binding capability.